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Mutations in SNRPE, which Encodes a Core Protein
of the Spliceosome, Cause Autosomal-Dominant
Hypotrichosis Simplex
Sandra M. Pasternack,1 Melanie Refke,1 Elham Paknia,2 Hans Christian Hennies,3,4,5
Thomas Franz,6 Niklas Scha¨fer,1,13 Alan Fryer,7 Maurice van Steensel,8,9 Elizabeth Sweeney,7
Miquel Just,10,14 Clemens Grimm,2 Roland Kruse,11 Carlos Ferra´ndiz,10 Markus M. No¨then,1,12
Utz Fischer,2 and Regina C. Betz1,*
Hypotrichosis simplex (HS) comprises a group of hereditary isolated alopecias that are characterized by a diffuse and progressive loss of
hair starting in childhood and shows a wide phenotypic variability. We mapped an autosomal-dominant form of HS to chromosome
1q31.3-1q41 in a Spanish family. By direct sequencing, we identified the heterozygous mutation c.1A>G (p.Met1?) in SNRPE that results
in loss of the start codon of the transcript.We identified the samemutation in a simplexHS case from the UK and an additionalmutation
(c.133G>A [p.Gly45Ser]) in a simplex HS case originating from Tunisia. SNRPE encodes a core protein of U snRNPs, the key factors of the
pre-mRNA processing spliceosome. Themissense mutation c.133G>A leads to a glycine to serine substitution and is predicted to disrupt
the structure of SNRPE. Western blot analyses of HEK293T cells expressing SNRPE c.1A>G revealed an N-terminally truncated protein,
and therefore the mutation might result in use of an alternative in-frame downstream start codon. Subcellular localization of mutant
SNRPE by immunofluorescence analyses as well as incorporation of mutant SNRPE proteins into U snRNPs was found to be normal, sug-
gesting that the function of U snRNPs in splicing, rather than their biogenesis, is affected. In this report we link a core component of the
spliceosome to hair loss, thus adding another specific factor in the complexity of hair growth. Furthermore, our findings extend the
range of human phenotypes that are linked to the splicing machinery.Hypotrichosis simplex (HS [MIM 146520, MIM 278150,
MIM 146550, MIM 613981, and MIM 605389]) is a heredi-
tary form of nonsyndromic, isolated alopecia that affects
men and women equally. Both autosomal-dominant and
autosomal-recessive patterns of inheritance have been
observed in a number of families. Hair loss is diffuse and
usually begins in early childhood, and then progresses
until adulthood. The extent of scalp and body hair involve-
ment can be very variable, within as well as between fami-
lies, and ranges from partial alopecia to complete loss of
scalp and body hair. The hair shaft characteristically shows
no gross abnormality.
Mutations in six genes have been identified for isolated
HS,1–6 and mutations in three of them—CDSN (MIM
602593),6 APCDD1 (MIM 607479),1 and RPL21 (MIM
603636)2—are responsible for autosomal-dominant forms.
Mutations in these latter genes are the pathogenic cause
for only a total of ten families with autosomal-dominant
HS, and therefore a large number of families and simplex
cases with hypotrichosis are so far unexplained.
To determine the molecular genetic basis of autosomal-
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The Amgeneration pedigree from Spain (Figure 1A). Most of the
affected family members present with scanty or no
eyebrows and additionally with a highly variable degree
of alopecia since birth, ranging from slight thinning of
scalp and axillary hair to complete loss of scalp and body
hair (Figures 1D–1H and 1M and Figure S1 available on-
line). Pubic hair remains mainly unaffected. Skin, nails,
teeth, and sweating are normal in these individuals and
no other abnormalities were detected. The clinical charac-
teristics and pedigree structure of the family have been
described in detail elsewhere.7
We collected blood samples from 12 family members, 6
of whom are affected. Ethical approval was obtained
from the ethics committee of the Medical Faculty of the
University of Bonn and all participants provided written
informed consent prior to blood sampling. The study
was conducted in concordance with the Declaration of
Helsinki Principles. DNA was extracted from peripheral
blood leukocytes according to standard methods.
We performed a genome-wide linkage analysis approach
by using 320 highly polymorphic microsatellite markers
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Figure 1. Pedigrees and Photographs of Affected Individuals from Three Different Hypotrichosis Simplex Families
(A) Pedigree of the Spanish hypotrichosis family. Affected family members are shown in black; circles and squares denote females and
males, respectively.
(B) Pedigree of the British family.
(C) Pedigree of the Tunisian family.
(D) Index case (III:3) of the Spanish family. The picture was taken when she was 10 years old. She shows complete alopecia of the scalp
and is devoid of eyebrows and eyelashes.
(E) Cousin of the index person at the age of 8 years. He has almost normal scalp hair, but sparse eyebrows and eyelashes.
(F) Cousin of the index person at the age of 10 years. His hair at the scalp is almost normal but he has no eyebrows and no eyelashes.
(G) Mother of the Spanish family. Her scalp hair is almost normal, but the eyebrows are sparse. Eyelashes are not visible.
(H and M) Father of the Spanish family. His scalp hair is sparse. Eyelashes and eyebrows are not present. Also, he does not have
axillary hair.
(I–K) Affected female individual of the British family with HS at the age of 12 years. She has sparse scalp hair and eyelashes. Eyebrows are
not present.
(L) Affected male individual of the Tunisian family at the age of 8 years. He shows complete alopecia of the scalp as well as absence of
eyebrows and eyelashes.(Table S1). Two-point LOD scores were calculated between
each marker locus and hypotrichosis, under the assump-
tion of autosomal-dominant inheritance with complete
penetrance, a frequency of 105 for the disease allele,
and equal allele frequencies for each marker, via the
LINKAGE version 5.21 software.8 We found evidence for
linkage to the marker D1S1660, with a maximum LOD
score of 2.3 at recombination fraction (q) 0 (Figure S2).
By genotyping additional markers in the identified region,
we narrowed the candidate region to 21 Mbp between82 The American Journal of Human Genetics 92, 81–87, January 10, 2markers D1S408 and D1S2141 (Figure S3). This region con-
tained more than 100 annotated genes. Because the iden-
tified region did not contain any obvious gene that was
functionally relevant for hair loss, we sequenced gene by
gene. Therefore, PCR was performed in a total volume of
25 ml with 40 ng of genomic DNA with the REDTaq Ready-
Mix PCR Reaction Mix with MgCl2 (Sigma Aldrich, Saint
Louis, MO). The PCR products were purified with the illus-
tra GFX PCR DNA and Gel Band Purification Kit (GE
Healthcare, Freiburg, Germany) and directly sequenced013
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Figure 2. Sequence and Expression Anal-
ysis of SNRPE
(A) Sequence analysis of SNRPE in the
Spanish family revealed a c.1A>G substitu-
tion that leads to the abolishment of the
start codon (left). The same mutation was
also identified in an affected individual
from Great Britain. Sequence analysis in
additional persons revealed a c.133G>A
substitution in aboy fromTunisia (middle).
Sequencing of cDNA samples of individual
II:7 of the Spanish family and a control,
indicating that the mutant RNA is present
(right). Arrow indicates the mutation.
(B) Multiple tissue expression analysis of
SNRPE revealed that the gene is expressed
ubiquitously, including expression in hair
follicles and skin.
(C) Expression analysis of SNRPE via
immortalized lymphocytes of individual
II:7 of the Spanish family and a healthy
control. We isolated RNA from the respec-
tive cells andperformed a reverse-transcrip-
tase PCR. The obtained cDNA was used
as template for a semiquantitative PCR
with SNRPE- and GAPDH-specific primers.
Negative control is shown on the right.on an ABI 3100 genetic analyzer (Applied Biosystems,
Foster City, CA) with the BigDye Terminator v1.1 Cycle
Sequencing kit (Applied Biosystems) and the DyeEx 2.0
Spin Kit for sample clean up (QIAGEN, Hilden, Germany).
After excluding 60 genes by direct sequencing (Table S2),
we identified a c.1A>G (p.Met1?) mutation in the start
codon of SNRPE (also known as Sm-E; MIM 128260; RefSeq
accession number NM_003094.2), which encodes a core
protein of pre-mRNA processing U-rich small nuclear
ribonucleoproteins (U snRNPs) (Figure 2A, left; primer
sequences are given in Table S3). Because the mutation
eliminates an NcoI restriction site, we performed an NcoI
digestion with SNRPE PCR products of members of Family
1 and observed that the mutation segregated with the
disorder (Figure S4). We then sequenced several cases of
our hypotrichosis cohort and detected the same mutation
in a simplex case from Great Britain (Figures 1I–1K). We
could not identify the mutation in the healthy parents,
indicating that themutation occurred de novo in that indi-
vidual (Figures 1B and S5). Paternity was confirmed by
analyzing microsatellite markers that were consistent in
the parents and their offspring (Figure S6). In another per-
son originating from Tunisia, we identified a c.133G>A
mutation (p.Gly45Ser) (Figure 2A, middle). Also in this
family, the individual is a simplex case because the noncon-
sanguineous parents were reported as being unaffected;
however, samples from the parents were not available (Fig-
ure 1C). We did not detect either of the two mutations inThe American Journal of Human880 control chromosomes of German
origin and 598 control chromosomes
of Spanish origin. The mutations
were also not present in dbSNP and
the 1000 Genomes database.SNRPE consists of five coding exons with a 279 bp
open reading frame encoding the 92 amino acid protein
SNRPE,9 alternatively termed Sm-E, which constitutes
a core component of U snRNPs. These RNA-protein parti-
cles are part of the spliceosome, which catalyzes the exci-
sion of introns from primary gene transcripts during the
splicing process. SNRPE is one out of seven related Sm
proteins (termed SNRPB [UniProtKB: P14678], SNRPD1
[UniProtKB: P62314], SNRPD2 [UniProtKB: P62316],
SNRPD3 [UniProtKB: P62318], SNRPE, SNRPF [UniProtKB:
P62306], and SNRPG [UniProtKB: P62308]) that assemble
onto U snRNAs to from the toroidal Sm core domain of
U snRNPs. This domain constitutes the structural frame-
work of most spliceosomal U snRNPs (U6 and U6actac
being two exceptions) and has been shown to be impor-
tant for their biogenesis and function.
To analyze the expression of SNRPE and genes encoding
other Sm proteins, we used the Human MTC Panel I and II
(BD Biosciences, Franklin Lakes, NJ) and also RNA isolated
from additional human tissues. After reverse-transcriptase
PCR, we performed semiquantitative PCRs by using gene-
specific primers (Table S3). Expression analysis in different
human tissues and cells revealed that SNRPE is expressed
ubiquitously including skin and hair follicle cells (Fig-
ure 2B). Consistent with a role in splicing, not only SNRPE
but also all other genes encoding Sm proteins are expressed
ubiquitously in the human body, including skin, lympho-
cytes, and hair follicle cells of the scalp and the eyebrowGenetics 92, 81–87, January 10, 2013 83
(Figure S7). To determine whether the mutant allele is
present in the RNA of affected individuals and not
degraded, we isolated RNA from immortalized lympho-
cytes of an affected individual from Family 1 and a control.
After cDNA synthesis and PCR with gene-specific primers,
we sequenced the obtained products and detected both the
wild-type and the mutant allele (Figure 2A, right, and 2C).
Via immunohistochemistry, we investigated in which
cells of the skin SNRPE is present. In sections of human
scalp skin we detected SNRPE immunoreactivity in the
nuclei of all cells of the hair follicle, the epidermis, and
the dermis (Figure S8), which could be completely blocked
by adding the immunogenic peptide to the antibody solu-
tion (data not shown). An identical pattern of SNRPE
immunoreactivity was observed in dorsal skin of 9-day-
old C57BL/6J mice (Figure S9). The nuclear localization
of the SNRPE immunoreactivity would be expected for
a protein involved in splicing.
Themutations identified in our affected individuals with
HS are predicted to have a major impact on gene expres-
sion or structure of SNRPE. The p.Gly45Ser substitution
leads to a change of a highly conserved glycine (Figures
S10 and S11). This amino acid lies within the so-called
Sm motif 1 that, together with an adjacent Sm motif 2,
allows formation of the Sm fold characteristic of the family
of Sm and LSm proteins (Figure S11).10 Structure-based
examination of the p.Gly45Ser substitution predicted
a clash with Leu58 in the Sm fold. Furthermore, the
substituted serine is supposed to disrupt the hydrophobic
core of the protein (Figure S12).
In contrast, the c.1A>G mutation alters the start codon
of SNRPE. The use of alternative initiator codons has
been suggested, but these non-ATG triplets are generally
less efficient and show a lower activity than the regular
ATG start codon.11 On the other hand, there is the possi-
bility that a downstream ATG might be used for the initia-
tion of translation. The growing number of start codon
mutations that have been described in the literature for
various genes and diseases points to their pathogenicity
in humans.12,13
Next, we assessed whether the pathogenic mutants are
expressed in vivo. For this purpose, the mutant and wild-
type genes were cloned into the eukaryotic expression
vector pcDNA3.1/V5-His (Invitrogen, Paisley, UK) and
transiently transfected in HEK293T cells (European Collec-
tion of Cell Cultures [ECACC]). Wild-type and mutant
(c.1A>G and c.133G>A) constructs allowed the transla-
tion of an 11 kDa protein, which corresponds to the
full-length SNRPE (Figure 3C), indicating that the initial
ATG as well as GTG can be used as a start codon during
translation. Interestingly, c.1A>G also allowed the produc-
tion of a weaker truncated version of 9 kDa, which most
probably arises from the initiation of translation at the
second in-frame ATG codon at position 14 (Figure 3C).
The second in-frame ATG is not embedded in a Kozak
consensus sequence, but the purine in position 3, which
is functionally the most important position in the Kozak84 The American Journal of Human Genetics 92, 81–87, January 10, 2consensus sequence, as well as the G in positionþ4, which
is also highly conserved, are still present and might
facilitate initiation of translation.14 Compared to the full-
length protein, however, the truncated form is less effi-
ciently translated (Figure 3E) and is mostly insoluble
(compare protein abundance in pellet versus soluble frac-
tion [Figure S13] upon cell extract preparation).
To further determine the subcellular localization of wild-
type and mutant SNRPE proteins, we performed immuno-
fluorescence analysis with transiently transfected COS7
cells. As expected for a core splice factor, SNRPE was found
in a speckled pattern within the nucleus of cells. In addi-
tion, the protein localized to discrete spots, which most
probably represent Cajal bodies. Notably, we found no
significant differences in the localization of the mutant
proteins in comparison to the wild-type protein (Figures
3A and 3B).
Next, we investigated whether mutant SNRPE incorpo-
rates into U snRNPs and is hence part of spliceosomal
complexes. For this, we expressed V5-tagged wild-type
and mutant SNRPE in HEK293T cells. Extracts from these
cells were then subjected to immunoprecipitation with
an antibody directed against the m3G-cap of U snRNPs.
Note that the truncated version of p.Met1? and the
p.Gly45Ser mutant were less abundant in these extracts
(Figure 3E). As shown in Figure 3C, these antibodies copre-
cipitated wild-type and mutant SNRPE, indicating that the
proteins have incorporated into U snRNPs. In the case of
p.Met1?, only a minor reduction in the efficiency of U
snRNP incorporation could be observed. However, in the
case of p.Gly45Ser, the reduction in the incorporation effi-
ciency is more substantial (Figure 3F).
Next, we investigated the presence of SNRPE in immor-
talized lymphocytes of individuals harboring the p.Met1?
substitution. By using a monoclonal antibody, we were
able to detect only full-length SNRPE in these cells, which
is incorporated into the Sm core with almost equal effi-
ciency to the wild-type protein of a healthy control
individual (Figure 3D). Because these cells contain the
mutant as well as the wild-type allele, it is currently
unclear whether they express the protein from the mutant
locus. However, the truncated version of SNRPE, which is
translated upon overexpression (see Figures 3C and S13),
was not detectable in these cells. This may indicate that
the protein is unstable in the cell line of the affected
person.
SNRPE is part of spliceosomal U snRNPs. Therefore, it
was interesting to test whether the SNRPE mutants would
interfere with splicing in vivo. To test this possibility, we
performed splicing analyses by using artificial minigenes
as well as lymphocyte cell lines of affected individuals.
When analyzing these model substrates, no major splicing
abnormalities were observed (see Figures S14 and S15).
However, at present, we cannot exclude the possibility
that SNRPEmutations cause subtle changes in the splicing
pattern of the target organ, i.e., the hair follicle of affected
persons.013
Figure 3. Protein Analyses of SNRPE Wild-Type and Mutant Constructs
(A and B) Subcellular localization of SNRPE wild-type (A) or p.Met1? (B) by immunofluorescence analysis. SNRPE shows a speckled
pattern within the nucleus of COS7 cells. In addition, the protein is enriched in discrete spots, which most probably represent Cajal
bodies. No significant difference in the localization of the wild-type and mutant SNRPE protein was observed. The nuclei are stained
with DAPI; DIC, differential interference microscopy.
(C) Immunoprecipitation of snRNPs with m3G-cap antibody (H20) from transfected HEK293T cells followed by western blot analysis
with V5 antibody. Western blotting with SNRPB antibody was used as a control for purification of the snRNPs. We observed that in
the case of p.Met1?, both full-length and truncated forms of the protein are translated, albeit at lower levels than the wild-type, and
incorporated into the Sm core. We conclude that the initial GTG can be used as a start codon during translation. Integration of
the truncated form of the protein (second in-frame ATG) proves that this alteration does not affect the early incorporation of the
protein into the Sm core. Interestingly, the substitution p.Gly45Ser is also incorporated into the Sm Core, although with a lower
efficiency.
(D) Immunoprecipitation of snRNPs with m3G-cap antibody (H20) from lymphocytes of a control and individual II:7 of the Spanish
family (p.Met1?) followed by western blot analysis with SNRPE antibody. Western blotting with SNRPB antibody was used as a control
for purification of the snRNPs. Interestingly, in cells of affected individuals, only full-length protein is produced and incorporated into
the Sm core with almost equal efficiency to the wild-type. Becauses of identical sizes, one cannot distinguish between wild-type and full-
length mutant protein in the cell line of the affected person.
(E) Normalized protein levels of SNRPE wild-type and mutant proteins in HEK293T cells. Quantification has been performed with the
results from three separate experiments. In each lane, the protein level has been normalized according to the signal of SNRPB in the
same lane and been shown as a percentage of the wild-type protein. Quantifications have been performed by the ImageJ program.
(F) Normalized efficiency of incorporation of wild-type and mutant SNRPE proteins into the Sm core in HEK293T cells. The efficiency of
incorporation in each lane has been normalized according to the signal of SNRPB in the same lane and also the protein level in the same
experiment. Quantification has been performed with the results from three separate experiments by the ImageJ program.By using a genetic linkage approach, we could associate
mutations in SNRPE with autosomal-dominant hypotri-
chosis simplex. SNRPE encodes a core splicing factor and
therefore is required in all nucleated cells of the bodyThe Amfor pre-mRNA maturation. The two mutations identified
here appear to affect the solubility of SNRPE and therefore
may be pathogenic because they reduce the soluble frac-
tion that can be incorporated into U snRNPs. Interestingly,erican Journal of Human Genetics 92, 81–87, January 10, 2013 85
however, for both mutants we observed a small fraction
of soluble protein, which can efficiently assemble into U
snRNPs. Hence, it is possible that the mutant SNRPE
proteins become part of the spliceosome but interfere at
an as-yet-to-be-identified step with the splicing process.
Of note, Weiss et al. reported a dominant Snrpe mutation
in a mouse strain that was identified in a mutagenesis
screen for hypogonadism. However, these mice show no
obvious skin or hair phenotype, which might be due to
the position of the mutation or due to different physiolog-
ical processes in mouse and human.15
In this report we identified a spliceosomal small nuclear
ribonucleoprotein that is involved in a specific hair pheno-
type. Interestingly, until now, mutations in a few genes en-
coding core splicing factors were known to cause human
pathogenic phenotypes. Among them are SNRNP200
(RP33, MIM 610359),16 PIM1-associated protein (RP9 or
PAP1, MIM 607331),17 PRPF31 (RP11, MIM 606419),18
PRPC8 (RP13, MIM 600059),19 and HPRP3 (RP18, MIM
601414)20 that have been linked to autosomal-dominant
retinitis pigmentosa (RP, MIM 268000). Interestingly, it
has been shown that mutations in the RP-associated splice
factors do not lead to a general defect in splicing. Rather,
tissue-specific alterations in the expression of a relatively
small number of transcripts have been found, most of
them being implicated in photoreceptor maintenance or
development. Thus, these data provide insight into how
mutations in general, and splice factors in particular, cause
a tissue-specific disease.21 Along the same lines, we may
speculate that mutations in SNRPE also lead to subtle
defects in the splicing machinery in a way that compro-
mises hair growth/development and thus leads to the
mild and specific phenotype. Analyzing the splicing
pattern in hair follicle cells of affected individuals in
comparison to unaffected individuals will provide further
insight into the etiology of HS. Alternatively, the reduced
protein levels of some mutant forms of SNRPE, as shown
in in vitro protein analyses, may also contribute to the
etiology of the disease.
Although the vast majority of SNRPE is part of splicing U
snRNPs, the protein is also an essential part of the U7
snRNP implicated in 30 end processing of replication-
dependent histone mRNAs. Thus, it is a possibility that
malfunction of U7 snRNP also contributes to the HS
phenotype. Clearly, future investigation of the transcrip-
tome of affected persons will give a deeper insight into
the underlying mechanisms.
In summary, mutations in SNRPE add to the growing list
of snRNP genes known to be responsible for different
human diseases. Our results contribute to a better under-
standing of the biology of the hair follicle and identify
that snRNPs play an important role in hair development.Supplemental Data
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